Atticus Wealth Management LLC Raises Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Atticus Wealth Management LLC increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 14.2% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 403 shares of the medical equipment provider’s stock after buying an additional 50 shares during the period. Atticus Wealth Management LLC’s holdings in Intuitive Surgical were worth $210,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of ISRG. Bennett Selby Investments LP grew its holdings in shares of Intuitive Surgical by 3.9% during the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock valued at $234,000 after purchasing an additional 17 shares during the last quarter. LVW Advisors LLC boosted its position in Intuitive Surgical by 1.3% during the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock valued at $756,000 after buying an additional 19 shares during the period. Wesbanco Bank Inc. grew its stake in shares of Intuitive Surgical by 1.6% during the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock valued at $635,000 after buying an additional 19 shares during the last quarter. Hazlett Burt & Watson Inc. increased its holdings in shares of Intuitive Surgical by 5.8% in the third quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock worth $177,000 after buying an additional 20 shares during the period. Finally, Mitchell Mcleod Pugh & Williams Inc. lifted its stake in shares of Intuitive Surgical by 4.1% in the 3rd quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock valued at $247,000 after acquiring an additional 20 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

ISRG opened at $584.05 on Monday. The stock has a market cap of $208.03 billion, a price-to-earnings ratio of 93.90, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. The firm’s fifty day moving average is $547.16 and its 200 day moving average is $504.78. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00.

Insiders Place Their Bets

In other Intuitive Surgical news, CEO Gary S. Guthart sold 18,151 shares of the stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the transaction, the chief executive officer now owns 24,219 shares in the company, valued at $12,391,166.97. This trade represents a 42.84 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Jamie Samath sold 270 shares of the business’s stock in a transaction dated Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the completion of the sale, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,730,093.55. This trade represents a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 42,453 shares of company stock worth $22,059,506 in the last three months. 0.90% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on ISRG. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Stifel Nicolaus lifted their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. Raymond James upped their target price on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday. Wells Fargo & Company lifted their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a report on Friday. Finally, Evercore ISI restated a “cautious” rating on shares of Intuitive Surgical in a report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average price target of $583.83.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.